ABSTRACT
Primary open-angle glaucoma is a neurodegenerative disease with progressive chronic optic neuropathy and corresponding visual field defects. In this literature review, we discuss systemic diseases and their mechanism for developing glaucoma, including systemic hypertension and hypotension, diabetes, dyslipidemia, obstructive sleep apnoea syndrome, chronic kidney disease, migraine, and polypharmacy.
Subject(s)
Glaucoma, Open-Angle , Glaucoma , Neurodegenerative Diseases , Optic Nerve Diseases , Humans , Glaucoma, Open-Angle/complications , Glaucoma, Open-Angle/diagnosis , Glaucoma, Open-Angle/therapy , Optic Nerve , Intraocular PressureABSTRACT
Ocular hypertension (OHT) refers to a condition in which the intraocular pressure increases without causing glaucomatous optic nerve changes or visual field damage. The incidence rate of OHT in people over 40 years old is as high as 4% to 10%. According to the OHT Treatment Study (OHTS), the incidence of primary open angle glaucoma (POAG) among OHT patients is increasing year by year, so it is necessary to conduct long-term follow-up. This article elaborates on five major risk factors for the progression of OHT to POAG: age, intraocular pressure, vertical cup-disc ratio, pattern standard deviation of visual field, and central corneal thickness. It also summarizes other potential risk factors, such as long-term fluctuations in intraocular pressure, asymmetry of intraocular pressure and visual field between the two eyes, structural phenotypes of the optic disk, and optic disk hemorrhage. Predicting the risk of OHT progression to POAG based on risk factors, patients with different risk levels require different timing for treatment initiation and follow-up intervals. Those with higher risks should start preventive treatment earlier and have shorter follow-up intervals. Both drug therapy and selective laser trabeculoplasty can serve as initial treatment options for OHT. Combining evidence-based medicine research and individualized evaluation of treatment can enhance the clinical diagnosis and treatment level of OHT.
Subject(s)
Evidence-Based Medicine , Glaucoma, Open-Angle , Ocular Hypertension , Humans , Ocular Hypertension/diagnosis , Ocular Hypertension/therapy , Risk Factors , Glaucoma, Open-Angle/diagnosis , Glaucoma, Open-Angle/therapy , Intraocular Pressure , Disease ProgressionABSTRACT
OBJECTIVES: To assess whether patients from minority ethnic groups have different perceptions about the quality-of-life outcomes that matter most to them. DESIGN: Cross-sectional observational study. SETTING: High volume eye centres serving the most ethnically diverse region in the UK, recruiting from July 2021 to February 2022. PARTICIPANTS: 511 patients with primary open-angle glaucoma and the predisease state of ocular hypertension. MAIN OUTCOME MEASURES: The main outcome was participants' self-reported priorities for health outcomes. RESULTS: Participants fell into one of four clusters with differing priorities for health outcomes, namely: (1) vision, (2) drop freedom, (3) intraocular pressure and (4) one-time treatment. Ethnicity was the strongest determinant of cluster membership after adjusting for potential confounders. Compared with white patients prioritising vision alone, the OR for black/black British patients was 7.31 (95% CI 3.43 to 15.57, p<0.001) for prioritising drop freedom; 5.95 (2.91 to 12.16, p<0.001) for intraocular pressure; and 2.99 (1.44 to 6.18, p=0.003) for one-time treatment. For Asian/Asian British patients, the OR was 3.17 (1.12 to 8.96, p=0.030) for prioritising intraocular pressure as highly as vision. Other ethnic minority groups also had higher ORs for prioritising health outcomes other than vision alone: 4.50 (1.03 to 19.63, p=0.045) for drop freedom and 5.37 (1.47 to 19.60, p=0.011) for intraocular pressure. CONCLUSIONS: Ethnicity is strongly associated with differing perceptions about the health outcomes that matter. An individualised and ethnically inclusive approach is needed when selecting and evaluating treatments in clinical and research settings.
Subject(s)
Glaucoma, Open-Angle , Quality of Life , Humans , Male , Female , United Kingdom , Cross-Sectional Studies , Aged , Glaucoma, Open-Angle/therapy , Glaucoma, Open-Angle/ethnology , Middle Aged , Intraocular Pressure , Ethnicity , Ocular Hypertension/ethnology , Ocular Hypertension/therapy , Health PrioritiesABSTRACT
Mutations in myocilin (MYOC) are the leading known genetic cause of primary open-angle glaucoma, responsible for about 4% of all cases. Mutations in MYOC cause a gain-of-function phenotype in which mutant myocilin accumulates in the endoplasmic reticulum (ER) leading to ER stress and trabecular meshwork (TM) cell death. Therefore, knocking out myocilin at the genome level is an ideal strategy to permanently cure the disease. We have previously utilized CRISPR/Cas9 genome editing successfully to target MYOC using adenovirus 5 (Ad5). However, Ad5 is not a suitable vector for clinical use. Here, we sought to determine the efficacy of adeno-associated viruses (AAVs) and lentiviruses (LVs) to target the TM. First, we examined the TM tropism of single-stranded (ss) and self-complimentary (sc) AAV serotypes as well as LV expressing GFP via intravitreal (IVT) and intracameral (IC) injections. We observed that LV_GFP expression was more specific to the TM injected via the IVT route. IC injections of Trp-mutant scAAV2 showed a prominent expression of GFP in the TM. However, robust GFP expression was also observed in the ciliary body and retina. We next constructed lentiviral particles expressing Cas9 and guide RNA (gRNA) targeting MYOC (crMYOC) and transduction of TM cells stably expressing mutant myocilin with LV_crMYOC significantly reduced myocilin accumulation and its associated chronic ER stress. A single IVT injection of LV_crMYOC in Tg-MYOCY437H mice decreased myocilin accumulation in TM and reduced elevated IOP significantly. Together, our data indicates, LV_crMYOC targets MYOC gene editing in TM and rescues a mouse model of myocilin-associated glaucoma.
Subject(s)
Cytoskeletal Proteins , Glaucoma, Open-Angle , Glycoproteins , Animals , Mice , CRISPR-Cas Systems , Disease Models, Animal , Eye Proteins/genetics , Eye Proteins/metabolism , Glaucoma, Open-Angle/genetics , Glaucoma, Open-Angle/therapy , Glaucoma, Open-Angle/metabolism , Intraocular Pressure/genetics , Lentivirus/genetics , Trabecular Meshwork/metabolismABSTRACT
This article is an English translation of the 4th Finnish Current Care Guideline for diagnostics, treatment and follow-up of primary open-angle glaucoma, normal-tension glaucoma and pseudoexfoliative glaucoma. This guideline is based on systematic literature reviews and expert opinions with Finland's geographical and operational healthcare environment in mind.
Subject(s)
Exfoliation Syndrome , Glaucoma, Open-Angle , Glaucoma , Humans , Glaucoma, Open-Angle/diagnosis , Glaucoma, Open-Angle/therapy , Exfoliation Syndrome/diagnosis , Exfoliation Syndrome/therapy , Finland/epidemiology , Intraocular PressureABSTRACT
PRCIS: Based on a large administrative database of German claims data, our study provides current estimates of the prevalence and incidence of primary open angle glaucoma (POAG) in Germany and describes selected outcomes for prevalent patients with POAG. PURPOSE: To estimate the prevalence and incidence of POAG in Germany, to describe the patient population in terms of comorbidity burden, routine care, and overall healthcare resource utilization (HCRU) and associated costs, and to describe treatment patterns over time in patients undergoing relevant laser procedures. MATERIALS AND METHODS: Based on anonymized German claims data, we carried out a retrospective, noninterventional study covering calendar years 2016-2021. RESULTS: For the adult German population (≥18 y), we estimated a POAG 1-year prevalence of 1.70% and a 1-year incidence of 0.17% in 2018; both increased with age, peaking in 80- to 89-year-olds. Prevalence and incidence were lower in 2020 (1.65% and 0.16%, respectively), the first year of the SARS-CoV-2 pandemic. Most patients solely received topical treatment. Most surgically treated patients underwent laser trabeculoplasty, followed by laser iridotomy, trabeculectomy, and filtration operations with implant. In patients undergoing laser trabeculoplasty, the treatment regimen was nearly unchanged in the second year after, compared with 2 years before the procedure. Multimorbidity was commonly observed; 75.5% of patients had arterial hypertension and 50.0% had disorders of lipoprotein metabolism and other lipidemias, compared with 60.1% and 39.2%, respectively, in an age- and sex-matched control sample. CONCLUSIONS: Our study provides insights into epidemiology and routine care of POAG in Germany and HCRU in prevalent patients. There was little change in treatment regimens in patients who underwent laser trabeculoplasty, 2 years after the procedure. Most patients were multimorbid highlighting the need for comprehensive care.
Subject(s)
Glaucoma, Open-Angle , Humans , Glaucoma, Open-Angle/epidemiology , Glaucoma, Open-Angle/therapy , Glaucoma, Open-Angle/surgery , Germany/epidemiology , Male , Female , Aged , Middle Aged , Retrospective Studies , Aged, 80 and over , Prevalence , Incidence , Adult , Trabeculectomy , Young Adult , Adolescent , COVID-19/epidemiology , Health Care Costs , Databases, Factual , SARS-CoV-2 , Laser TherapyABSTRACT
Resumo Objetivo: Avaliar a relação custo-utilidade do tratamento inicial com laser ou medicamentos do glaucoma primário de ângulo aberto (GPAA) no Brasil, considerando de um lado os custos totais e de outro lado o impacto na qualidade de vida dos pacientes. Métodos: O estudo foi realizado com base em um modelo de Markov, onde uma coorte teórica de portadores de GPAA em estágio inicial foi gerada. Os parâmetros usados no modelo foram obtidos na literatura e incluíram: custos médicos diretos (consultas, exames, tratamento); custos não médicos diretos (gasto com hospedagem, transporte, alimentação, acompanhante); custos indiretos (relacionados à incapacidade para o trabalho); valores de utilidade (qualidade de vida medida em QALY - quality-adjusted life year); e probabilidade de transição entre os estágios de saúde. Três estratégias de tratamento foram testadas no modelo: (1) sem tratamento; (2) tratamento inicial com colírios; (3) tratamento inicial com trabeculoplastia a laser. A medida de desfecho foi a razão de custo-utilidade incremental (RCUI). A robustez do modelo foi testada através de análise de sensibilidade. Resultados: As estratégias (2) e (3) de tratamento inicial do GPAA geraram ganhos em qualidade de vida em relação à (1) no Brasil. Iniciar o tratamento com laser gerou ganho médio de 1 QALY, enquanto que com medicamentos propiciou um ganho de 2 QALYs em média. Dentre as três estratégias testadas, a estratégia (2) foi a custo-efetiva e foi dominante sobre as demais, pois foi ao mesmo tempo a mais barata e a mais efetiva. Conclusão: Tanto a trabeculoplastia a laser quanto os medicamentos como tratamentos primários do GPAA inicial geraram ganhos significativos de qualidade de vida. A estratégia de se iniciar o tratamento com medicações foi custo-efetiva, quando se considera os custos totais. A alternativa de tratamento inicial através de trabeculoplastia a laser não foi custo-efetiva.
Abstract Objective: To evaluate the cost-utility relation of the initial treatment with laser or primary open-angle glaucoma medications (PLA) in Brazil, considering on the one hand the total costs and on the other side the impact on patients' quality of life. Methods: The study was performed based on a Markov model, where a theoretical cohort of early-stage GPAA carriers was generated. The parameters used in the model were obtained in the literature and included: direct medical costs (consultations, examinations, treatment); direct non-medical costs (accommodation, transportation, meals, companions); indirect costs (related to incapacity for work); utility values (quality of life measured in QALY - quality-adjusted life year); and probability of transition between stages of health. Three treatment strategies were tested in the model: (1) without treatment; (2) initial treatment with eye drops; (3) initial treatment with laser trabeculoplasty. The measure of outcome was the incremental cost-utility ratio (RCUI). The robustness of the model was tested through sensitivity analysis. Results: The strategies (2) and (3) of the initial treatment of POAG generated gains in quality of life in relation to (1) in Brazil. Initiating the laser treatment generated an average gain of 1 QALY, whereas with medication it gave a gain of 2 QALYs on average. Among the three strategies tested, strategy (2) was cost-effective and was dominant over the other strategies, since it was at the same time the cheapest and the most effective strategy. Conclusion: Both laser trabeculoplasty and medications as primary treatments of early-stage POAG have generated significant gains in quality of life. The strategy of starting treatment with medications was cost-effective, whereas laser trabeculoplasty strategy was not cost-effective, when non-medical costs (direct and indirect) are included.
Subject(s)
Quality of Life , Glaucoma, Open-Angle/drug therapy , Glaucoma, Open-Angle/therapy , Cost-Benefit Analysis , Laser Therapy , BrazilABSTRACT
ABSTRACT Purpose: To correlate provocative test-based intraocular pressure (IOP) variation parameters (fluctuation and peak) with functional status, and to compare these IOP parameters between treated eyes with asymmetric primary open-angle glaucoma (POAG). Methods: A prospective observational study including consecutively treated patients with primary open-angle glaucoma was performed. Subjects with ocular diseases other than glaucoma or previous incisional glaucoma surgery were excluded. The primary inclusion criteria were 33 visual field tests and 32 years of follow-up, without any changes on current medical regimen. Long-term intraocular pressure parameters were acquired via isolated intraocular pressure measurements from the patients' last 5 office visits. To evaluate provocative test-based intraocular pressure parameters, all patients were submitted to a water drinking test. Initially, the partial correlation coefficients between each intraocular pressure variation parameter and visual field mean deviation were calculated, adjusting for the baseline intraocular pressure and number of antiglaucoma medications. In addition, each intraocular pressure parameter was compared between eyes with better visual field mean deviation and fellow eyes with worse visual field mean deviation in patients with asymmetric visual field loss (defined as an inter-eye visual field mean deviation difference of at least 3 dB). Results: A total of 87 eyes (87 patients; mean age, 61.9 ± 12.5 years; 59.8% women) with primary open-angle glaucoma were included. The patients underwent a median of 5 visual field tests, with a mean follow-up of 4.3 ± 1.4 years. Neither long-term nor water-drinking test intraocular pressure variation parameters were significantly associated with visual field mean deviation values (p30.117). In the subgroup with asymmetric visual field loss (64 eyes of 32 patients; mean age, 65.0 ± 11.4 years), neither long-term water-drinking test intraocular pressure variation parameters differed significantly between eyes with better and worse visual field mean deviation (p30.400). Conclusion: Our results indicate that neither long-term intraocular pressure variation parameters nor stress test-derived intraocular pressure metrics, as assessed by the water-drinking test, appear to correlate with the visual field status or differ significantly between eyes with asymmetric visual field damage, suggesting that other factors may explain such functional asymmetry, and that the water-drinking test does not add significant information to these cases.
RESUMO Objetivo: Correlacionar os parâmetros de variação da pressão intraocular (flutuação e pico) com o dano funcional em pacientes tratados com glaucoma primário de ângulo aberto, e comparar esses parâmetros de pressão intraocular entre olhos com dano funcional assimétrico. Métodos: Estudo observacio nal prospectivo foi realizado incluindo consecutivamente pa cientes tratados com glaucoma primário de ângulo aberto. Foram excluídos indivíduos com outras doenças oculares que não o glaucoma ou cirurgia prévia incisional de glaucoma. Os principais critérios de inclusão foram: 33 testes de campo visual e 32 anos de acompanhamento, sem quaisquer alterações no regime medicamentoso atual. Parâmetros de pressão intraocular de longo prazo foram obtidos através de medidas de pressão intraocular isoladas de cada consulta (as últimas 5 consultas de cada paciente foram consideradas para análise). Para avaliação dos parâmetros de pressão intraocular de curto prazo, todos os pacientes foram submetidos ao teste de sobrecarga hídrica. Ini cialmente, calculamos os coeficientes de correlação parcial de cada parâmetro de variação da pressão intraocular com o nível de dano funcional, baseado no índice Mean Deviation (MD), ajustando para a pressão intraocular basal e o número de medicações antiglaucomatosas. Além disso, comparamos cada parâmetro de pressão intraocular entre os olhos com melhor e pior nível de dano funcional em pacientes com perda de campo visual assimétrica (definida como diferença no índice mean deviation entre os olhos de pelo menos 3 dB). Resultados: Foram incluídos 87 olhos (87 pacientes) com glaucoma primário de ângulo aberto. A idade média foi de 61,9 ± 12,5 anos e 59,8% eram mulheres. Em geral, os pacientes foram submetidos a 5 testes (mediana) de campo visual, com um seguimento médio de 4,3 ± 1,4 anos. Nem os parâmetros de variação da pressão intraocular de longo prazo nem aqueles obtidos pelo teste de sobrecarga hídrica se correlacionaram significativamente com o nível de dano no campo visual (p30,117). No subgrupo com perda de campo visual assimétrica (64 olhos de 32 pacientes; idade média, 65,0 ± 11,4 anos), nem os parâmetros de variação da pressão intraocular de longo prazo nem os obtidos pelo teste de sobrecarga hídrica diferiram significativamente entre olhos com melhor e pior nível de dano funcional (p3 0,400). Conclusão: Nossos resultados indicam que não apenas parâmetros de variação da pressão intraocular de longo prazo, mas também medidas de pressão intraocular derivadas do teste de sobrecarga hídrica, não parecem se correlacionar com o nível de dano do campo visual, nem diferem significativamente entre olhos com nível de dano funcional assimétrico. Esses achados sugerem que outros fatores poderiam explicar essa assimetria funcional e que o teste de sobrecarga hídrica não acrescenta informações significativas a esses casos.
Subject(s)
Humans , Male , Female , Middle Aged , Aged , Glaucoma, Open-Angle/physiopathology , Intraocular Pressure/physiology , Reference Values , Time Factors , Tonometry, Ocular , Water/physiology , Visual Fields/physiology , Glaucoma, Open-Angle/therapy , Prospective Studies , Statistics, Nonparametric , Visual Field TestsABSTRACT
RESUMO Objetivo: Identificar os custos não médicos diretos e indiretos em uma população de pacientes portadores de glaucoma primário de ângulo aberto (GPAA) em tratamento no Brasil. Métodos: A pesquisa dos custos neste estudo transversal foi realizada através de entrevista a uma população de pacientes portadores de GPAA em acompanhamento em um centro de referência para o tratamento do glaucoma na cidade de Juiz de Fora - MG. Para avaliação dos custos não médicos diretos, as seguintes variáveis foram investigadas: gasto com transporte, hospedagem, alimentação e acompanhante para cada consulta. Já na análise dos custos indiretos, avaliou-se: recebimento ou não de benefício social por causa do glaucoma (aposentadoria ou auxílio-doença) e qual o valor anual e perda de dias trabalhados pelo paciente e/ou pelo acompanhante. Os valores médios anuais foram calculados para todo o grupo e para cada estágio evolutivo do glaucoma. Resultados: Setenta e sete pacientes foram incluídos nesta análise (GPAA inicial: 26,0%; GPAA moderado: 24,7% e GPAA avançado: 49,3%). A média do custo não médico direto foi (em reais): 587,47; 660,52 e 708,54 para os glaucomas iniciais, moderados e avançados, respectivamente. Já a média do custo indireto foi: 20.156,75 (GPAA inicial); 26.988,16 (moderado) e 27.263,82 (avançado). Conclusão: Os custos não médicos diretos e indiretos relacionados ao GPAA no Brasil foram identificados. Os custos indiretos são superiores aos custos não médicos diretos e ambos tendem a aumentar com o avanço da doença.
ABSTRACT Objective: To identify direct and indirect non-medical costs in a population of patients with primary open-angle glaucoma (POAG) receiving treatment in Brazil. Methods: In this cross-sectional study, we obtained the costs through an interview with a population of patients with POAG at a glaucoma referral clinic in the city of Juiz de Fora - MG. In order to assess the direct non-medical costs, we investigated the following variables transportation expenses, lodging expenses, food and companion expenses for each visit. In the indirect costs analysis, we assessed the following variables: whether or not social benefits were received because of glaucoma (retirement or sickness benefit) and the annual value and loss of days worked by the patient and/or the companion. We calculated the mean annual values for the whole group and for each glaucoma stage. Results: Seventy-seven patients were included in this analysis (initial POAG: 26.0%, moderate POAG: 24.7% and advanced POAG 49.3%). The mean non-medical direct cost was (in reais): 587.47; 660.52 and 708.54 for the initial, moderate and advanced glaucomas, respectively. The mean indirect cost was: 20,156.75 (initial POAG); 26,988.16 (moderate POAG) and 27,263.82 (advanced POAG). Conclusion: We identified the direct and indirect non-medical costs related to POAG in Brazil. Indirect costs are higher than non-medical direct costs and both tend to increase with disease progression.
Subject(s)
Humans , Male , Female , Aged , Glaucoma, Open-Angle/economics , Health Expenditures , Cost of Illness , Financing, Personal/economics , Office Visits/economics , Brazil , Glaucoma, Open-Angle/therapy , Cross-Sectional Studies , Health Care Costs , Costs and Cost AnalysisABSTRACT
Para el año 2020 se estima que existirán alrededor de 79,6 millones de personas con glaucoma y aproximadamente 5,9 millones de ciegos bilaterales por esta afección. El glaucoma primario de ángulo abierto ocupa el segundo lugar dentro de las principales causas de ceguera en el mundo, solo superado por la catarata. Entre sus factores de riesgo se encuentran: la presión intraocular elevada, la excavación papilar aumentada, la edad, el antecedente heredofamiliar, las pruebas estructurales alteradas y los campos visuales anormales. No obstante, los factores de riesgo aterosclerótico también han sido involucrados en su posible desarrollo y progresión. El presente trabajo tiene como objetivo analizar las consecuencias socioeconómicas que generan el glaucoma primario de ángulo abierto y los factores de riesgo ateroesclerótico, como hipertensión arterial, diabetes mellitus, dislipidemias, tabaquismo , sexo, color de piel y obesidad(AU)
It has been estimated that by the year 2020 there will be about 79.6 million people with glaucoma, and about 5.9 million bilaterally blind people due to this condition. Primary open-angle glaucoma is the second cause of blindness worldwide, only surpassed by cataract. Its risk factors include high intraocular pressure, increased papillary excavation, age, hereditary factors, altered structural tests, and abnormal visual fields. However, atherosclerotic risk factors have also been related to its potential development and progression. The present study is aimed at analyzing the socioeconomic consequences of primary open-angle glaucoma and atherosclerotic risk factors such as hypertension, diabetes mellitus, dyslipidemias, smoking, sex, skin color and obesity(AU)
Subject(s)
Humans , Atherosclerosis , Glaucoma, Open-Angle/therapy , Risk Factors , Socioeconomic Survey , Visual FieldsABSTRACT
La extracción de la catarata produce una significante y sustancial reducción de la presión intraocular en individuos con glaucoma de ángulo abierto, hipertensión ocular y glaucoma por cierre angular. Remover la catarata mejora la interpretación de las pruebas perimétricas. Es recomendable restablecer las imágenes de base del nervio óptico, así como el campo visual después de la extracción de la catarata. La secuencia de cirugía de catarata y cirugía de glaucoma disminuye la probabilidad de complicaciones y aumenta el éxito quirúrgico. Tiene múltiples beneficios realizar la cirugía de catarata antes que la cirugía de glaucoma, mientras que la cirugía de catarata después de la trabeculectomía incrementa el riesgo de fallo de la filtración. Como la cirugía de glaucoma mínimamente invasiva continúa mejorando en términos de eficacia, esta juega un rol importante en la cirugía combinada de glaucoma y catarata en pacientes con glaucoma en estadios inicial y moderado. La combinación de cirugía de catarata con implante valvular o trabeculectomía por uno o dos sitios, también ofrece ventajas en pacientes con glaucoma avanzado. La presente revisión tiene como objetivo resumir el papel de la cirugía de catarata en el tratamiento del glaucoma teniendo en cuenta el efecto en la presión intraocular y las ventajas que ofrece en aquellos pacientes con ambas condiciones(AU)
Cataract extraction produces a significant, substantial reduction in intraocular pressure in people with open-angle glaucoma, ocular hypertension and angle closure glaucoma. Cataract removal improves the interpretation of perimetric tests. After cataract extraction it is advisable to re-establish the base optic nerve images and the visual field. The cataract surgery - glaucoma surgery sequence reduces the chances of complications and increases surgical success. It is very beneficial to perform cataract surgery before glaucoma surgery, whereas cataract surgery following trabeculectomy increases the risk of filtration failure. Minimally invasive glaucoma surgery continues to improve in terms of efficacy, thus playing an important role in combined glaucoma-cataract surgery in patients with early-stage, moderate glaucoma. Combined cataract surgery and valve implant or one- or two-site trabeculectomy is also advantageous in patients with advanced glaucoma. The present review is aimed at summarizing the role of cataract surgery in the treatment of glaucoma in terms of its effect on intraocular pressure and its advantages for patients with both conditions. Key words: phacoemulsification, cataract, glaucoma, trabeculectomy, combined surgery, MIGS(AU)
Subject(s)
Humans , Combined Modality Therapy/adverse effects , Glaucoma, Open-Angle/therapy , Phacoemulsification/adverse effects , Trabeculectomy/methodsABSTRACT
ABSTRACT Normal-tension glaucoma (NTG) is a progressive optic neuropathy with intraocular pressure (IOP) within the statistically normal range (≤21 mmHg). The prevalence of NTG varies widely among different population studies, being the most prevalent open-angle glaucoma subtype in some reports. The etiology of NTG possibly is multifactorial and still not well defined. Alternative treatments have been proposed based on pathogenesis details. However, in clinical practice, adequate reduction of IOP remains the keystone of managing patients with NTG. We review the pathogenesis of NTG and the available therapies for this optic neuropathy.
RESUMO O glaucoma de pressão normal (GPN) é uma neuropatia óptica progressiva que cursa com a pressão intraocular (PIO) dentro da faixa de normalidade (≤21 mmHg). A prevalência do glaucoma de pressão normal varia entre os estudos populacionais, sendo em alguns o principal subtipo de glaucoma primário de ângulo aberto. A etiologia do glaucoma de pressão normal possivelmente é multifatorial e ainda não foi totalmente esclarecida. Tratamentos alternativos baseados nos diferentes detalhes da patogenia foram recentemente propostos. Entretanto, na prática clínica, a redução adequada da pressão intraocular continua sendo a base do tratamento do glaucoma de pressão normal. O objetivo deste artigo é revisar a patogênese do glaucoma de pressão normal e as formas de terapia disponíveis.
Subject(s)
Humans , Low Tension Glaucoma/physiopathology , Low Tension Glaucoma/pathology , Low Tension Glaucoma/therapy , Intraocular Pressure/physiology , Visual Fields/physiology , Glaucoma, Open-Angle/physiopathology , Glaucoma, Open-Angle/pathology , Glaucoma, Open-Angle/therapy , Risk Factors , Disease Progression , Diagnosis, DifferentialABSTRACT
La pseudoexfoliación es una alteración de la matriz extracelular fuertemente asociada a catarata y glaucoma secundario de ángulo abierto. Relacionada con la edad avanzada y más común en mujeres, es una enfermedad sistémica con típicas alteraciones en el ojo que hacen más difícil la cirugía, especialmente la debilidad zonular y la poca dilatación pupilar. Los pacientes con pseudoexfoliación operados de catarata, requieren un seguimiento posoperatorio más cuidadoso para detectar y tratar tempranamente las complicaciones posoperatorias como es la contracción capsular del caso que presentamos y que resolvió con tratamiento de Yag Láser en los bordes de la capsulorrexis(AU)
Pseudoexfoliation is an extracelular matrix alteration closely associated with cataract and secondary open angle glaucoma. Older age-related and more common in women, it is a systemic illness with typical alterations in the eye such as zonular weakness and little pupil dilation, which makes the surgery more difficult. The patients with pseudoexfoliation and caratact surgery require a more careful postoperative follow-up to early detect and to treat the postoperative complications such as the capsular contraction of the case reported in this paper, which was treated with Yag Laser in the capsulorhexis borders(AU)
Subject(s)
Humans , Female , Aged, 80 and over , Capsulorhexis/adverse effects , Cataract Extraction/methods , Exfoliation Syndrome/complications , Glaucoma, Open-Angle/therapy , Lasers, Solid-State/therapeutic useABSTRACT
RESUMO Objetivo: Determinar a estratégia mais custo-efetiva para o tratamento do glaucoma primário de ângulo aberto em fase inicial, comparando-se as seguintes alternativas: observação, tratamento clínico ou tratamento com laser. Métodos: Por meio de um modelo de Markov, sob a perspectiva do Sistema Único de Saúde (SUS) e um horizonte da expectativa de vida média da população brasileira. Comparou-se a razão de custo-utilidade incremental (ICUR) entre 3 alternativas de tratamento, assim como seus custos e o ganho em qualidade de vida, medido em QALY (Quality-adjusted life years). Resultados: A ICUR do tratamento inicial com laser e do tratamento inicial com colírios, em relação a não tratar foi de R$ 2.811,39/QALY e R$ 3.450,47/QALY, respectivamente. Ambas as estratégias foram custo-efetivas, com uma discreta vantagem para o tratamento a laser. Esta diferença diminui ainda mais quando se aumenta a idade de entrada no modelo. As duas alternativas propiciaram ganhos significativos de qualidade de vida (em torno de 2,5 QALYs para o tratamento com laser e de 5,0 QALYs para o tratamento com colírios). Conclusão: Tanto o tratamento primário com trabeculoplastia a laser quanto com medicações foram custo-efetivos e proporcionaram ganhos reais de qualidade de vida quando comparados com o não tratamento do GPAA.
ABSTRACT Objective: To determine the most cost-effective strategy for the treatment of early-stage primary open-angle glaucoma, by comparing the following alternatives: observation, medical therapy or laser treatment. Methods: Using a Markov model, from the perspective of the Brazilian Public Health System (SUS) and a horizon of the average life expectancy of the Brazilian population, we compared the incremental cost-utility ratio (ICUR) among the three treatment alternatives, as well as their costs and the gain in quality of life as measured in QALYs (Quality-adjusted life years). Results: The ICUR of initial laser treatment and initial medical treatment over observation only, was R$ 2,811.39/QALY and R$ 3,450.47/QALY, respectively. Both strategies were cost-effective, with a slight advantage for the laser treatment. This difference decreases further when increasing age into the model. The two alternatives have provided significant gains in quality of life (around 2.5 QALYs for the laser treatment and 5.0 QALYs for treatment with eye drops). Conclusion: Both primary treatments, with laser trabeculoplasty as well as with medications, were cost-effective and provided real gains in quality of life when compared with no treatment of POAG.
Subject(s)
Humans , Adult , Glaucoma, Open-Angle/economics , Glaucoma, Open-Angle/therapy , Health Care Costs , Cost-Benefit Analysis , Costs and Cost Analysis , Quality of Life , Unified Health System/economics , Brazil , Trabeculectomy/economics , Life Expectancy , Markov Chains , Quality-Adjusted Life Years , Laser Therapy/economics , Models, TheoreticalSubject(s)
Aged , Female , Humans , Male , Middle Aged , Glaucoma, Open-Angle/physiopathology , Intraocular Pressure/physiology , Reference Values , Time Factors , Tonometry, Ocular , Water/physiology , Visual Fields/physiology , Glaucoma, Open-Angle/therapy , Prospective Studies , Statistics, Nonparametric , Visual Field TestsABSTRACT
PURPOSE: Non-penetrating deep sclerectomy (NPDS) has emerged as a viable option in the surgical management of open-angle glaucoma. Our aim is to assess the cost-effectiveness of NPDS and to compare it to maximum medical treatment in a 5-year follow-up. METHODS: A decision analysis model was built. Surgical (NPDS) arm of the decision tree was observational (consecutive retrospective case series) and maximum medical treatment arm was hypothetical. Maximum medical therapy was considered a three-drug regimen (association of a fixed combination of timolol/dorzolamide [FCTD] and a prostaglandin analogue [bimatoprost, latanoprost or travoprost]). Cost-effectiveness ratio was defined as direct cost (US dollars) for each percentage of intraocular pressure (IOP) reduction. Horizon was 5 years and perspective is from the public health care service in Brazil (SUS). Incremental cost-effectiveness ratio (ICER) was calculated. RESULTS: Direct cost for each percentage of IOP reduction in 5 years (cost-effectiveness ratio) was US$ 10.19 for NPDS; US$ 37.45 for the association of a FCTD and bimatoprost; US$ 39.33 for FCTD and travoprost; and US$ 41.42 for FCTD and latanoprost. NPDS demonstrated a better cost-effectiveness ratio, compared to maximum medical therapy. The ICER was negative for all medical treatment options; therefore NPDS was dominant. CONCLUSIONS: Despite some limitations, NPDS was both less costly and more effective than maximum medical therapy. From the Brazilian public health perspective, it was the most cost-effective treatment option when compared to maximum medical therapy (FCTD and prostaglandin).
OBJETIVO: A esclerectomia profunda não penetrante (EPNP) é uma opção viável para o tratamento cirúrgico do glaucoma de ângulo aberto. O objetivo deste estudo é avaliar a relação custo-efetividade da EPNP e compará-la com terapia clínica máxima (TCM) em um acompanhamento de 5 anos. MÉTODOS: Um modelo de análise de decisão foi proposto comparando-se o tratamento cirúrgico (EPNP) versus a TCM. A avaliação da EPNP foi observacional retrospectiva de uma série consecutiva de casos e da TCM foi hipotética. A TCM foi considerada como o uso de três drogas (associação de uma combinação fixa de timolol/dorzolamida [CFTD] e um análogo de prostaglandina [bimatoprosta, latanoprosta ou travoprosta]). A relação custo-efetividade foi definida com o custo direto (em dólares) para cada porcentual de redução da pressão intraocular (PIO). A razão de custo-efetividade incremental (ICER) foi calculada. O seguimento foi de 5 anos e a perspectiva dos custos é do Sistema Único de Saúde (SUS). RESULTADOS: O custo direto para cada porcentual de redução da PIO ao final de 5 anos (relação custo-efetividade) foi de US$ 10,19 para a EPNP; US$ 37,45 para a CFTD + bimatoprosta; US$ 39,33 para CFTD + travoprosta; e US$ 41,42 para CFTD + latanoprosta. A EPNP apresentou uma melhor relação custo-efetividade, quando comparada com a TCM. O índice ICER foi negativo, portanto a EPNP foi a opção terapêutica dominante. CONCLUSÃO: A EPNP foi menos custosa e mais efetiva que a TCM. Do ponto de vista do SUS, ela foi a opção mais custo-efetiva, quando comparada com a TCM.
Subject(s)
Humans , Middle Aged , Antihypertensive Agents/economics , Glaucoma, Open-Angle/economics , Sclerostomy/economics , Antihypertensive Agents/therapeutic use , Brazil , Cost-Benefit Analysis , Drug Therapy, Combination , Follow-Up Studies , Glaucoma, Open-Angle/therapy , Prostaglandins, Synthetic/economics , Prostaglandins, Synthetic/therapeutic use , Retrospective Studies , Sclerostomy/methods , Sulfonamides/economics , Sulfonamides/therapeutic use , Thiophenes/economics , Thiophenes/therapeutic use , Timolol/economics , Timolol/therapeutic useABSTRACT
O glaucoma de pressão normal é neuropatia óptica caracterizada por diminuição da camada de fibras nervosas da retina, aumento da relação escavação/disco e defeito de campo visual, porém sem evidência de aumento da pressão intra-ocular. Os pacientes com glaucoma de pressão normal constituem um grupo heterogêneo em que várias condições sistêmicas podem ser encontradas e apresentam sinais clínicos oculares somente facilmente identificados nos estágios muito avançados da doença. E seu tratamento apresenta desafios maiores do que os existentes no tratamento dos glaucomas hipertensivos. O presente texto propõe uma revisão da patogênese e do diagnóstico diferencial, discutindo os aspectos vasculares, reumáticos, neurológicos e genéticos que devem ser investigados, assim como do tratamento dessa doença. Os autores pesquisaram os bancos de dados do PubMed (MEDLINE), LILACS e Cochrane Library (CENTRAL).
Subject(s)
Humans , Glaucoma/diagnosis , Diagnosis, Differential , Diagnostic Techniques, Ophthalmological , Glaucoma, Open-Angle/diagnosis , Glaucoma, Open-Angle/physiopathology , Glaucoma, Open-Angle/therapy , Glaucoma/physiopathology , Glaucoma/therapy , Intraocular PressureABSTRACT
El glaucoma cronico simple constituye la tercera causa de ceguera e invalidez visual en el mundo. Teniendo en cuenta el mecanismo de accion de la ozonoterapia y de la magnetoterapia y la fisiopatologia de la enfermedad se realizo un estudio para evaluar el efecto terapeutico de estas tecnicas en el glaucoma cronico simple. Se estudiaron 200 pacientes, en distintos estadios de la enfermedad, a los que se les aplico 3 esquemas de tratamiento: ozono, campo magnetico y la combinacion de ambos. Se midio la funcion visual, la nerviosa y la presion intraocular. Se obtuvo mejoria de la agudeza visual entre 69 y 72 por ciento del campo visual entre 59 y 76 por ciento. Hubo tendencia a la disminucion de la presion intraocular y a la disminucion en la latencia del P100 (potenciales evocados visuales). Estos resultados demostraron la efectividad del tratamiento impuesto y la recuperacion funcional de fibras nerviosas parcialmente inactivas